Preferred Label : KCNQ1 wt Allele;
NCIt synonyms : LQT1; Kv7.1; LQT; ATFB1; KCNA8; WRS; JLNS1; KCNA9; KVLQT1; SQT2; Potassium Voltage-Gated Channel, KQT-Like Subfamily, Member 1 wt Allele; RWS; FLJ26167; Kv1.9; Potassium Channel, Voltage-Gated, Shaker-Related Subfamily, Member 9 Gene; Jervell and Lange-Nielsen Syndrome 1 Gene; ATFB3; Potassium Channel, Voltage-Gated, KQT-Like Subfamily, Member 1 Gene;
NCIt definition : Human KCNQ1 wild-type allele is located in the vicinity of 11p15.5 and is approximately
404 kb in length. This allele, which encodes potassium voltage-gated channel subfamily
KQT member 1 protein, plays a role in the regulation of both cardiac repolarization
and potassium transport. Mutations in the gene are associated with hereditary long
QT syndrome, Romano-Ward syndrome, Jervell and Lange-Nielsen syndrome and familial
atrial fibrillation.;
NCIt note : The KCNQ1 gene is located in a region of chromosome 11 that contains a large number
of contiguous genes that are abnormally imprinted in cancer and the Beckwith-Wiedemann
syndrome.;
GenBank Accession Number : AF000571;
Origin ID : C75623;
UMLS CUI : C2697834;
OMIM relation
- See also inter- (CISMeF)
- Semantic type(s)
- concept_is_in_subset
- gene_found_in_organism
- gene_in_chromosomal_location
- gene_is_element_in_pathway
- gene_plays_role_in_process
https://www.academie-medecine.fr/risques-pour-les-enfants-en-contact-etroit-avec-des-animaux-de-compagnie-non-traditionnels-acnt-dans-les-lieux-publics/
2024
France
scientific and technical information
NON Mouse
MET Mutation Analysis Was Not Performed
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
PDGFRA Mutation Analysis Was Not Performed
Lymph Node Dissection Was Not Performed
First Degree Family History Thyroid Cancer Negative
No History of Non-Cardiac Surgery
Therapeutic Ionizing Radiation to Head History Absent
RET Rearrangement Analysis Was Not Performed
No History of Rheumatic Fever
Physical Contact
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New
Tumor Event
Neither Case or Control Status
MGMT Promoter Methylation Testing Was Not Performed
Additional Surgery for New Tumor Event Absent
No Response to Intervention for Kawasaki Disease
SDH Complex Mutation Analysis Was Not Performed
KRAS Mutation Analysis Was Not Performed
Contact Person
Family History of Stomach Cancer Absent
Any Metastatic Diagnosis Absent
BRAF Rearrangement Analysis Was Not Performed
Adjuvant Post-operative Immunological Therapy Was Not Administered
ROS1 Rearrangement Analysis Was Not Performed
Unemployed
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Tumor Reoccurrence Absent After Initial Treatment
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
NF1 Mutation Analysis Was Not Performed
No Known History of Alcohol Use
History of Colorectal Cancer Negative
No History of Neonatal Complication
Medication Not Taken
Documentation Absent
Paraneoplastic Syndrome is Not Present
KCNQ1 wt Allele
Tumor Progression Absent After Initial Treatment
EGFR Gene Amplification Negative
Caffeine Not Routinely Consumed
BRAF Mutation Analysis Was Not Performed
Cancer History Absent
Not Lost to Follow-Up
ATRX Gene Mutation Negative
Regional Anesthesia was not Administered
Nitric Oxide Measurement
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Offspring
Neither
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Additional Immunohistochemistry Was Not Performed
IDH Family Wildtype
Chemical/Occupational Exposure Absent
Adjuvant I-131 Therapy Negative
First Degree Family History Cancer Negative
risk
child, nos
Negation
Intervention Not Given for Kawasaki Disease
ATRX Mutation Analysis Was Not Performed
No Known History of Illicit Drug Use
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
Nitric Oxide
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Patient was Not Previously Evaluated for Current Chief Complaint
First Degree Family History of Primary Brain Tumor Negative
Chief Complaint Not Caused by Trauma
Other Preoperative IV Medications were not Administered
Additional Molecular Studies Were Not Performed
EGFR Amplification Analysis Was Not Performed
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Radiation History Negative
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
EGFR Mutation Analysis Was Not Performed
Communication Contact
pets
1p/19q Deletion Analysis Was Not Performed
Chief Complaint was Not Witnessed
animal, nos
Preoperative IV Antacids were not Administered
New Tumor Event After Initial Treatment Absent
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
No History of Gestational Complication
Preoperative IV Opiates were not Administered
IV Anesthesia was not Administered
Narrow
panthera uncia
Has No Sibling
Adjuvant Post-operative Radiation Therapy Was Not Administered
Preoperative IV Antiemetics were not Administered
KIT Mutation Analysis Was Not Performed
Radiation Therapy Not Received
New Disease is not Multifocal
Adjuvant Post-operative Chemotherapy Was Not Administered
PTEN Mutation Analysis Was Not Performed
History of Medical Treatment Absent
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Physician Diagnosed Diabetes Absent
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Chemotherapy Not Received
No History of Myopathy
PTEN Gene Mutation Negative
Minor Criteria for Rheumatic Heart Disease Not Present
ERBB2 Mutation Analysis Was Not Performed
TP53 Mutation Analysis Was Not Performed
Local Anesthesia Agents were not Administered
Norway
Patient was not Postmenopausal with no Prior Oophorectomy
IDH Family Mutation Analysis Was Not Performed
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
NRAS Mutation Analysis Was Not Performed
No History of Kawasaki Disease
Child
Routine Cytogenetics Were not Completed
Preoperative IV Sedation was Not Administered
child
Another Form of Birth Control was not Used
ALK Rearrangement Analysis Was Not Performed
Evidence of Disease Absent after Completion of Therapy
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
No History of Congenital Heart Disease
Hypertension Absent
Use of Smokeless Tobacco at Time of Diagnosis Negative
Fluorescence In Situ Hybridization Was Not Performed
Intercurrent Illness is Absent at Onset of Chief Complaint
10q23/PTEN Locus Deletion Analysis Was Not Performed
Public
narrowing, nos
---
https://www.academie-medecine.fr/attention-au-contact-etroit-des-enfants-au-domicile-avec-des-animaux-de-compagnie-non-traditionnels-acnt/
2024
France
scientific and technical information
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
Medication Not Taken
Radiation History Negative
Other Preoperative IV Medications were not Administered
NRAS Mutation Analysis Was Not Performed
PTEN Gene Mutation Negative
Nitric Oxide
ROS1 Rearrangement Analysis Was Not Performed
MET Mutation Analysis Was Not Performed
Documentation Absent
residence characteristics
KRAS Mutation Analysis Was Not Performed
Preoperative IV Antiemetics were not Administered
animal, nos
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
First Degree Family History of Primary Brain Tumor Negative
Intervention Not Given for Kawasaki Disease
panthera uncia
Additional Surgery for New Tumor Event Absent
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
pets
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New
Tumor Event
Not Lost to Follow-Up
Negation
System Alert
Minor Criteria for Rheumatic Heart Disease Not Present
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
EGFR Amplification Analysis Was Not Performed
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Tumor Reoccurrence Absent After Initial Treatment
narrowing, nos
Cancer History Absent
First Degree Family History Thyroid Cancer Negative
domicile
Adjuvant Post-operative Immunological Therapy Was Not Administered
Has No Sibling
attention
Additional Immunohistochemistry Was Not Performed
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
EGFR Mutation Analysis Was Not Performed
KIT Mutation Analysis Was Not Performed
IV Anesthesia was not Administered
child, nos
Contact Person
Patient was Not Previously Evaluated for Current Chief Complaint
Chemotherapy Not Received
ATRX Mutation Analysis Was Not Performed
Local Anesthesia Agents were not Administered
New Tumor Event After Initial Treatment Absent
Preoperative IV Antacids were not Administered
Patient was not Postmenopausal with no Prior Oophorectomy
History of Colorectal Cancer Negative
Routine Cytogenetics Were not Completed
NF1 Mutation Analysis Was Not Performed
SDH Complex Mutation Analysis Was Not Performed
Narrow
Adjuvant I-131 Therapy Negative
MGMT Promoter Methylation Testing Was Not Performed
Caffeine Not Routinely Consumed
BRAF Rearrangement Analysis Was Not Performed
PTEN Mutation Analysis Was Not Performed
IDH Family Wildtype
Intercurrent Illness is Absent at Onset of Chief Complaint
Fluorescence In Situ Hybridization Was Not Performed
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
No History of Non-Cardiac Surgery
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
10q23/PTEN Locus Deletion Analysis Was Not Performed
Family History of Stomach Cancer Absent
Warning
Hypertension Absent
Another Form of Birth Control was not Used
IDH Family Mutation Analysis Was Not Performed
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
No History of Myopathy
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
No History of Neonatal Complication
Neither
No Response to Intervention for Kawasaki Disease
PDGFRA Mutation Analysis Was Not Performed
History of Medical Treatment Absent
Evidence of Disease Absent after Completion of Therapy
NON Mouse
No History of Rheumatic Fever
No History of Kawasaki Disease
Nitric Oxide Measurement
Adjuvant Post-operative Radiation Therapy Was Not Administered
No History of Gestational Complication
BRAF Mutation Analysis Was Not Performed
Norway
Communication Contact
child
Lymph Node Dissection Was Not Performed
Chief Complaint Not Caused by Trauma
Use of Smokeless Tobacco at Time of Diagnosis Negative
Chemical/Occupational Exposure Absent
Adjuvant Post-operative Chemotherapy Was Not Administered
Physical Contact
Any Metastatic Diagnosis Absent
Chief Complaint was Not Witnessed
RET Rearrangement Analysis Was Not Performed
Preoperative IV Opiates were not Administered
Unemployed
attention, nos
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Paraneoplastic Syndrome is Not Present
No Known History of Illicit Drug Use
EGFR Gene Amplification Negative
Physician Diagnosed Diabetes Absent
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
ERBB2 Mutation Analysis Was Not Performed
TP53 Mutation Analysis Was Not Performed
New Disease is not Multifocal
ATRX Gene Mutation Negative
Offspring
ALK Rearrangement Analysis Was Not Performed
Child
Additional Molecular Studies Were Not Performed
Therapeutic Ionizing Radiation to Head History Absent
Preoperative IV Sedation was Not Administered
Neither Case or Control Status
First Degree Family History Cancer Negative
Radiation Therapy Not Received
KCNQ1 wt Allele
No Known History of Alcohol Use
No History of Congenital Heart Disease
1p/19q Deletion Analysis Was Not Performed
Tumor Progression Absent After Initial Treatment
Regional Anesthesia was not Administered
---
